4-(2-Bromo-6-fluorobenzoyl)-N-(pyridin-3-yl)-1H-pyrrole-2-carboxamide, 98.0%, 25mg

4-(Benzyloxy)-2-methylbenzoic acid, 95.0%, 250mg

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(tert-butylthio)-D-cysteine, 95+%, 25g

(S)-2-amino-3-(4-nitrophenyl)propan-1-ol, 95+%, 500mg

(R)-1-(5-Nitropyridin-2-yl)pyrrolidin-3-amine hydrochloride, 95.0%, 1g

N-Succinimidyl Maleimidoacetate>95.0%(qNMR)100mg

[2-(4-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl)ethyl]amine dihydrochloride, 95.0%, 1g

3,4-Difluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 97%, 1g

2-(4-Bromothiophen-2-yl)acetic acid, 95.0%, 5g

1-(5-Pyrimidinyl)ethanone, 95.0%, 25g

3'-Bromo-2,2,2-trifluoroacetophenone, 98.0%, 10g

9-Methoxy-1,2,3,4-tetrahydropyrazino[1,2-a]indole, 97%, 100mg

(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride, 98%, 5g